Xuekui Liu

9PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Micro- and nanosystemsMolecular targetsAcoustics and noise control (excl. architectural acoustics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 03, 2025
Loss of Nuclear Profilin 1 Triggers Oncogenic Reprogramming of Mammary Epithelial Cells Through Dysregulated DNA Replication in Breast Cancer.

Zheng Zhao, Yingbin Huang, Junhao Mai

|Jul 24, 2025
Cadonilimab (a PD-1/CTLA-4 Bispecific Antibody) plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase II Clinical Trial.

Fei Cao, Yan Li, Qi Fang

|Mar 12, 2024
Neoadjuvant chemo-immunotherapy with camrelizumab plus nab-paclitaxel and cisplatin in resectable locally advanced squamous cell carcinoma of the head and neck: a pilot phase II trial.

Di Wu, Yong Li, Pengfei Xu

|May 23, 2023
Biomimetic Nanoparticle with Glutathione Depletion and Amplified ROS Generation Capabilities for Synergistic Chemo-Sonodynamic Therapy in Squamous Cell Carcinomas.

Yunyun Fan, Pengfei Xu, Qi Fang

|Mar 06, 2023
USP7- and PRMT5-dependent G3BP2 stabilization drives de novo lipogenesis and tumorigenesis of HNSC.

Nan Wang, Tianzi Li, Wanyu Liu

|Feb 24, 2023
A proposed grading scheme for predicting recurrence in medullary thyroid cancer based on the Ki67 index and metastatic lymph node ratio.

Pengfei Xu, Di Wu, Xuekui Liu

Pageof 2

Frequent Collaborators

4 joint publications

Zheng Zhao

4 joint publications

Fei Cao

4 joint publications

Di Wu

3 joint publications

Pengfei Xu